IS4837A - Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa - Google Patents

Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa

Info

Publication number
IS4837A
IS4837A IS4837A IS4837A IS4837A IS 4837 A IS4837 A IS 4837A IS 4837 A IS4837 A IS 4837A IS 4837 A IS4837 A IS 4837A IS 4837 A IS4837 A IS 4837A
Authority
IS
Iceland
Prior art keywords
neutralization
inhibit elastase
pyrrolopyrrolone
derivatives
pyrrolopyrrolone derivatives
Prior art date
Application number
IS4837A
Other languages
English (en)
Inventor
Dennis Dowle Michael
Finch Harry
Andrew Harrison Lee
George Adam Inglis Graham
Redpath Johnson Martin
John Fawcett Macdonald Simon
Shah Pritom
Andrew Smith Robin
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9606508.1A external-priority patent/GB9606508D0/en
Priority claimed from GBGB9623001.6A external-priority patent/GB9623001D0/en
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS4837A publication Critical patent/IS4837A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS4837A 1996-03-28 1998-08-28 Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa IS4837A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9606508.1A GB9606508D0 (en) 1996-03-28 1996-03-28 Chemical componds
GBGB9623001.6A GB9623001D0 (en) 1996-11-05 1996-11-05 Chemical compounds
PCT/EP1997/001530 WO1997036903A1 (en) 1996-03-28 1997-03-26 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Publications (1)

Publication Number Publication Date
IS4837A true IS4837A (is) 1998-08-28

Family

ID=26309008

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4837A IS4837A (is) 1996-03-28 1998-08-28 Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa

Country Status (30)

Country Link
US (3) US5994344A (is)
EP (1) EP0891362B1 (is)
JP (1) JP4118337B2 (is)
KR (1) KR20000005039A (is)
CN (1) CN1067075C (is)
AP (1) AP823A (is)
AR (1) AR006401A1 (is)
AT (1) ATE261969T1 (is)
AU (1) AU726649B2 (is)
BR (1) BR9708449A (is)
CA (1) CA2250209A1 (is)
CO (1) CO4790152A1 (is)
CZ (1) CZ309798A3 (is)
DE (1) DE69728139T2 (is)
DK (1) DK0891362T3 (is)
EA (1) EA001437B1 (is)
EE (1) EE9800335A (is)
ES (1) ES2217404T3 (is)
HU (1) HUP9900567A3 (is)
IL (1) IL125859A0 (is)
IS (1) IS4837A (is)
NO (1) NO984470L (is)
NZ (1) NZ331490A (is)
PE (1) PE55298A1 (is)
PL (1) PL329153A1 (is)
PT (1) PT891362E (is)
SK (1) SK132498A3 (is)
TR (1) TR199801935T2 (is)
WO (1) WO1997036903A1 (is)
YU (1) YU41198A (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719189D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd New therapeutic method
GB9719172D0 (en) 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
GB9719187D0 (en) * 1997-09-09 1997-11-12 Glaxo Group Ltd Compounds
PE107899A1 (es) * 1997-09-09 1999-11-17 Glaxo Group Ltd Derivados de pirrolopirrolona como inhibidores de elastasa leucocitaria
GB9821199D0 (en) * 1998-09-30 1998-11-25 Glaxo Group Ltd Chemical compounds
GB9905418D0 (en) * 1999-03-09 1999-05-05 Glaxo Group Ltd Process
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
TW201018661A (en) 2003-03-14 2010-05-16 Ono Pharmaceutical Co Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
US7692037B2 (en) * 2004-09-02 2010-04-06 Eastman Chemical Company Optimized liquid-phase oxidation
GB2418427A (en) 2004-09-02 2006-03-29 Univ Cambridge Tech Ligands for G-protein coupled receptors
NZ553696A (en) 2004-09-13 2010-02-26 Ono Pharmaceutical Co Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
GB0512238D0 (en) * 2005-06-15 2005-07-27 Univ Cambridge Tech Anti-inflammatory agents
EA200870344A1 (ru) 2006-03-10 2009-04-28 Оно Фармасьютикал Ко., Лтд. Азотсодержащее гетероциклическое производное и фармацевтическое средство, включающее такое производное в качестве активного ингредиента
MX2009011533A (es) * 2007-04-23 2010-04-07 Siga Technologies Inc Productos quimicos, composiciones y metodos para tratamiento y prevencion de infecciones de virus orthopox y enfermedades asociadas.
WO2009065131A1 (en) 2007-11-16 2009-05-22 Rigel Pharmaceuticals, Inc. Carboxamide, sulfonamide and amine compounds for metabolic disorders
JP5650540B2 (ja) 2007-12-12 2015-01-07 ライジェル ファーマシューティカルズ， インコーポレイテッド 代謝障害のためのカルボキサミド、スルホンアミド、およびアミン化合物
CN106928211B (zh) 2008-04-23 2020-09-08 里格尔药品股份有限公司 用于治疗代谢障碍的甲酰胺化合物
AU2013363783B2 (en) * 2012-12-18 2018-02-08 Chiesi Farmaceutici S.P.A. Novel compounds
CA3154761A1 (en) 2019-09-17 2021-03-25 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
JP2023522010A (ja) 2020-04-16 2023-05-26 メレオ バイオファーマ ４ リミテッド α１－アンチトリプシンの欠損により媒介される呼吸器系疾患の処置のための好中球エラスターゼ阻害剤アルベレスタットに関連する方法
IL312002A (en) 2021-10-20 2024-06-01 Mereo Biopharma 4 Ltd Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2932650A (en) * 1957-11-19 1960-04-12 Arthur C Cope 2-6-diazabicyclo (3. 3. 0) octanes
US4997950A (en) * 1989-04-20 1991-03-05 Richard Finbar Murphy Novel C-terminal gastrin antagonists
GB9211783D0 (en) * 1992-06-04 1992-07-15 Ici Plc Amide derivatives
GB9402680D0 (en) * 1994-02-11 1994-04-06 Zeneca Ltd Pyrrolidine derivatives
US5610296A (en) * 1994-12-05 1997-03-11 G. D. Searle & Co. Process for the preparation of amidino phenyl pyrrolidine beta-alanine urea analogs

Also Published As

Publication number Publication date
AP823A (en) 2000-04-25
AU726649B2 (en) 2000-11-16
AP9801351A0 (en) 1998-09-30
CA2250209A1 (en) 1997-10-09
BR9708449A (pt) 1999-08-03
DE69728139T2 (de) 2004-10-21
EP0891362B1 (en) 2004-03-17
ATE261969T1 (de) 2004-04-15
HUP9900567A2 (hu) 1999-06-28
NO984470L (no) 1998-11-25
HUP9900567A3 (en) 2001-02-28
DK0891362T3 (da) 2004-07-12
US5994344A (en) 1999-11-30
PE55298A1 (es) 1998-09-19
US6057457A (en) 2000-05-02
US6215002B1 (en) 2001-04-10
CN1067075C (zh) 2001-06-13
AR006401A1 (es) 1999-08-25
ES2217404T3 (es) 2004-11-01
CO4790152A1 (es) 1999-05-31
EA199800773A1 (ru) 1999-06-24
WO1997036903A1 (en) 1997-10-09
JP2000507950A (ja) 2000-06-27
DE69728139D1 (de) 2004-04-22
PL329153A1 (en) 1999-03-15
SK132498A3 (en) 1999-08-06
TR199801935T2 (xx) 1999-03-22
JP4118337B2 (ja) 2008-07-16
KR20000005039A (ko) 2000-01-25
NO984470D0 (no) 1998-09-25
EA001437B1 (ru) 2001-02-26
YU41198A (sh) 1999-09-27
CN1219935A (zh) 1999-06-16
EP0891362A1 (en) 1999-01-20
PT891362E (pt) 2004-08-31
EE9800335A (et) 1999-04-15
NZ331490A (en) 2000-06-23
AU2291797A (en) 1997-10-22
IL125859A0 (en) 1999-04-11
CZ309798A3 (cs) 1999-02-17

Similar Documents

Publication Publication Date Title
IS4837A (is) Pýrrólópýrrólón afleiður sem latar fyrir hlutleysis elastasa
FI960525A0 (fi) Framstaellning av mellandestillat
FI961551A0 (fi) Menylett utforming av kortmeddelanden
FI962166A0 (fi) Foerfarande foer bestaemmande av utbredningsdaempning av radiovaogor
IS5391A (is) Pýrrólópýrrólón afleiður sem latar fyrir hlutleysiskirnings elastasa
IS5394A (is) Pýrrólópýrrólón afleiður sem latar fyrir hlutleysiskirnings elastasa
FI960501A0 (fi) Foerfarande foer omkastning av uppkopplingsriktningen av samtal
KR970058483U (ko) 건조기
ATA83196A (de) Wäschetrockner
KR970063497U (ko) 연속식 건조기
FI961041A0 (fi) Klingledare av saogmaskin
FI960962A0 (fi) Foerfarande foer framstaellning av en flerskiktskartongprofil
IT1282129B1 (it) Asciugabiancheria
KR970055619U (ko) 건조기
SE9600547D0 (sv) Bineg algoritmen
FI963207A0 (fi) Antennkonstruktion foer eliminering/minskning av de biologiska skadeverkningarna av en ficktekfons mikrovaogsstaolningsfaelt
KR970058653U (ko) 크레센트
KR980001183U (ko) 렌치
FI961657A0 (fi) Anordning foer foermogning av spannmaolsprodukter
FI961042A0 (fi) Foerfarande foer framstaellning av stanoler
FI961973A0 (fi) Anordning foer bearbetning av skogsmark
FI961878A0 (fi) Foerfarande foer framstaellning av plastprodukter
FI961733A0 (fi) Anordning foer sortering av virke
FI962119A0 (fi) Anordning oefr uppvaermning av babymjoelk
FI961569A0 (fi) Flerstegstrycksil foer silning av fibermassa